Abstract-In this work, tissue stiffness estimates are used to differentiate between benign and malignant breast masses in a group of pre-biopsy patients. The rationale is that breast masses are often stiffer than healthy tissue; furthermore, malignant masses are stiffer than benign masses. The comb-push ultrasound shear elastography (CUSE) method is used to noninvasively assess a tissue's mechanical properties. CUSE utilizes a sequence of simultaneous multiple laterally spaced acoustic radiation force (ARF) excitations and detection to reconstruct the region of interest (ROI) shear wave speed map, from which a tissue stiffness property can be quantified. In this study, the tissue stiffnesses of 73 breast masses were interrogated. The mean shear wave speeds for benign masses (3.42 ± 1.32 m/s) were lower than malignant breast masses (6.04 ± 1.25 m/s). These speed values correspond to higher stiffness in malignant breast masses (114.9 ± 40.6 kPa) than benign masses (39.4 ± 28.1 kPa and p < 0.001), when tissue elasticity is quantified by Young's modulus. A Young's modulus >83 kPa is established as a cut-off value for differentiating between malignant and benign suspicious breast masses, with a receiver operating characteristic curve (ROC) of 89.19% sensitivity, 88.69% specificity, and 0.911 for the area under the curve (AUC).
I. Introduction M ammography and conventional B-mode ultrasound (US) are the most common diagnostic methods for the detection of breast masses. Conventional B-mode US is used as an adjunct to mammography for breast imaging to improve sensitivity [1] [2] [3] [4] . However, B-mode US has shown low specificity in the differentiation of benign from malignant breast masses [5] [6] [7] [8] [9] . To increase specificity, breast masses are categorized according to the Breast Imaging-Reporting and Data System (BI-RADS) criteria defined by the American College of Radiology (ACR) [10] , [11] . Although increasing the specificity for malignant breast masses, the BI-RADS criteria generate several false-positive results leading to a number of unnecessary biopsies of benign breast masses [12] .
Shear wave elastography is an emerging field that assesses a tissue's pathology based on its mechanical properties [13] . The premise is that malignant tissue is usually stiffer than benign tissue [14] , [15] . Sarvazyan et al., proposed shear wave elasticity imaging (SWEI) [16] as a medical imaging modality. This modality employs acoustic radiation force (ARF) beams to generate shear waves within a tissue. The tissue stiffness is quantified from the measured shear wave speed. The most common breast SWEI methods are shear wave imaging using acoustic radiation force impulse (ARFI) [17] and SuperSonic Imagine (SSI) [18] , [19] . The ARFI shear wave imaging method employs an impulsive ARF to generate shear waves. Thereafter, pulse-echo ultrasound is used to track the shear wave in tissue. The measured shear wave speed is used to calculate the tissue stiffness [20] [21] [22] . SSI utilizes multiple consecutive ultrasound pulses to exert radiation force and establishes a supersonic regime of moving source to generate approximately planar shear waves in the tissue. The motion of the tissue is captured at a high frame rate using a plane-wave imaging technique [18] , [19] , [23] . The SSI system then creates a two-dimensional shear wave speed map. This information is used to estimate the tissue elasticity at each location expressed in units of kilopascals (kPa) [24] [25] [26] [27] [28] [29] [30] [31] [32] .
Song et al. [33] , [34] recently developed an ultrasound shear elastography technique called comb-push ultrasound shear elastography (CUSE) that uses multiple simultaneous laterally spaced ARF push beams. With CUSE, one can obtain a full field of view (FOV) shear wave speed, with a single push-detect data acquisition. The relatively short acquisition time of CUSE makes it less sensitive to interfering body or physiological motions (such as cardiac and breathing motions). In CUSE, the ARF push beams are laterally spaced to produce shear waves. The entire FOV is filled with shear waves traveling in both lateral directions (left-to-right and right-to-left). Thereafter, with the use of a directional filter, shear waves traveling in opposing directions are separated and used to assess the speed map of the full FOV under the transducer in one single comb-push acquisition [35] . CUSE in vivo studies have been recently presented on differentiation of thyroid nodules [36] and initial results of breast cancer detection [37] . In this study, updates in the differentiation between benign and malignant breast masses using CUSE from our previous study [37] are presented. In comparison to the previous study, our cohort has increased from 54 to 73 patients with an additional 13 benign breast masses. A receiver operating characteristic curve analysis of our previous study established an optimal Young's modulus cut-off value >83 kPa with 87.10% sensitivity, 82.61% specificity and 0.88 area under the curve (AUC). The cohort of our study is described, as well as the statistical results of the CUSE performance are presented. Also, initial findings correlating stiffness with the histopathological characteristics of benign and malignant breast masses are discussed.
II. Methods and Materials

A. CUSE Imaging Method and System
CUSE is implemented on a Verasonics V-1 system (Verasonics Inc., Kirkland, WA, USA), a fully programmable ultrasound platform equipped with a linear array transducer. The ARF beams can be either unfocused (UCUSE) or focused (FCUSE) [33] , as shown in Fig. 1 , depending on the depth of the mass. The FCUSE is used for deeper breast masses (>1 cm).
Upon excitation of the tissue, the Verasonics system immediately switches to plane-wave imaging mode to track the resulting shear wave propagation. The shear wave particle velocity is tracked by the compounding plane-wave imaging method and calculated by the 1-D autocorrelation method using the in-phase/quadrature (IQ) data [29] , [34] , [38] . The push beams generate shear waves in the tissue, with some waves interfering with each other constructively and destructively. To construct a robust shear wave speed map, a directional filter is used to extract the leftto-right (LR) and the right-to-left (RL) propagating shear waves from the interfering waves at each pixel. Thereafter, a time-of-flight algorithm based on cross-correlating shear wave motion profiles along the lateral direction was used to calculate shear wave propagation speed [38] . A threshold is imposed on the normalized cross-correlation coefficient used during the shear wave speed calculation as a shear wave quality control factor. Shear wave speeds with cross-correlation coefficients below this threshold were rejected. Thereafter, the final shear wave speed map is obtained by averaging LR and RL speed maps. The threshold is based on the quality of the final shear wave speed map. Quantitative measurements of tissue elasticity are obtained as the Young's modulus calculated from the mean shear wave speed of the tissue ROI. Assuming a linear, isotropic, incompressible, and elastic soft tissue the Young's modulus is obtained from the expression
where ρ = 1000 kg/m 3 is the density of the tissue and c s is the shear wave speed.
To demonstrate the ability of CUSE to differentiate stiff masses from soft materials, a phantom experiment was conducted. A CIRS spherical inclusion phantom (Model 059, Computerized Imaging Reference Systems Inc., Norfolk, VA, USA) was used for our phantom experiment. This phantom is a breast elastography phantom (sound speed of 1540 m/s, ultrasound attenuation of 0.5 dB/cm/MHz, and density of 1030 kg/m 3 ) with an inclusion shear wave speed about 1.73 times greater than that of the background. In Fig. 2(a) , an inclusion situated in a homogeneous phantom is excited by FCUSE ARF beams at a 4.09 MHz center frequency with 600 µs pulse duration. To track the resulting shear wave propagation, a three-angle compounding plane-wave imaging at a 5 MHz center frequency is utilized. 
B. In Vivo Human Study
Under a protocol approved by the Mayo Clinic Institutional Review Board (IRB), a total of 73 female patients with suspicious breast masses on their clinical evaluation were selected for this study. All of our patients have received a clinical ultrasound and mammography before participating in the study. CUSE was performed before biopsy in all cases. A written signed informed consent, approved by the Mayo Clinic IRB, was obtained from enrolled patients. We excluded patients with a history of breast implants and mastectomies. The histology of the breast masses were established only from the core biopsy results. The lesions were categorized as benign and malignant.
CUSE evaluations were performed while the patient was in a supine or lateral oblique position. Conventional B-mode US was first performed to identify the area of the mass by an experienced sonographer. Thereafter, the probe was fixed in place by a lockable articulated arm. This breast mass area was marked on the image by freehand drawing, to identify the ROI. To reduce possible breathing motion artifacts, the patients were asked to momentarily suspend their respiration for each CUSE measurement. The histology of the masses was established only from core biopsy results. The breast masses were categorized as benign or malignant.
III. Results and Discussion
The pathological diagnoses were 36 benign and 37 malignant masses. Benign and malignant breast masses showed mean shear wave speeds of 3.42 ± 1.32 m/s and 6.04 ± 1.25 m/s, respectively. The corresponding Young's modulus values are 39.4 ± 28.1 kPa and 114.9 ± 40.6 kPa for benign and malignant breast masses (p < 0.001), respectively. Note that the average normal breast tissue stiffness for our cohort has a Young's modulus of 14.1 ± 11.8 kPa. Applying the Young's modulus cut-off value >83 kPa yields a receiver operating characteristic (ROC) curve analysis of 89.19% sensitivity, 88.89% specificity and 0.911 area under the curve (AUC). This is an improvement to the 87.10% sensitivity, 82.61% specificity and 0.88 AUC obtained from our previous study [37] . The cut-off elasticity value (>83 kPa) is concordant with the >80 kPa in previous studies [25] , [37] , [39] for suspicious breast mass. Table I shows the sensitivity and specificity values for our study and previous studies, along with the AUC for a ROC analysis.
Although shear wave cut-off of >50 kPa (Evans et al. [28] ) and >60 kPa (Barr [40] ) have been reported, it should be noted that their patient cohorts are vastly different from our patient population. Evans et al. had 4% and 38% of their benign breast masses from BIRADS 2 and 3. We recruited patients with suspicious breast masses mainly composed of BIRADS 4 and 5.
A few selected cases are reviewed in Fig. 3 . In Figs. 3(a) and 3(b), a US B-mode image and the CUSE shear wave speed map of a 6-mm (in the greatest dimension) benign intramammary lymph node are shown. The breast mass region (marked in red) has a Young's modulus of 30.9 kPa. In Figs. 3(c) and 3(d) , an 8-mm benign fibroadenoma mass with myxoid change and apocrine metaplasia has a Young's modulus of 6.22 kPa. In Figs. 3(e) and 3(f), a 14-mm malignant mass with grade II invasive ductal carcinoma (IDC) has a Young's modulus of 111.9 kPa. In Figs. 3(g) and 3 (h), a 16-mm malignant mass with grade I IDC has a Young's modulus of 83.3 kPa.
The pathology of the 36 benign masses are shown in Table II . It should be noted that some benign masses have mixed pathologies. These masses are classified by the pathology likeliest to result in the higher elasticity or placed in the other category. CUSE correctly identified 9 fibroadenomas for an elasticity cut-off value >83 kPa. The mean stiffness of fibroadenomas was 24.79 ± 20.42 kPa. Breast masses with fibrocystic change (n = 5) and papilloma (n = 6) have mean elasticity values of 37.69 ± 2.47 kPa and 32.44 ± 24.31 kPa, respectively. Of the 16 benign masses classified with other histology, four were classified as false positives by CUSE with a stiffness values higher than 100 kPa. Three of these benign masses had calcifications (n = 2) and complex sclerosing (n = 1). Calcifications have been shown to increase stiffness estimates in elastography evaluations [41] . Meanwhile, because of its fibrous structure complex sclerosing can induce false positives. The other false positives, were atypical ductal hyperplasia (n Chang et al. [25] cut-off >80.17 (kPa)
Berg et al. [39] cut-off >80 (kPa)
Barr [40] cut-off >60 (kPa)
Evans et al. [28] cut-off >50 (kPa) = 1) and granulomatous inflammation (n = 1) composition. Atypical ductal hyperplasia is known to be a possible precursor to malignancy. Table III presents the histopathology of the malignant breast masses. Mixed-pathology masses are classified by the type likeliest to result in higher elasticity. The invasive status of the breast masses were ductal carcinoma in situ (DCIS) (n = 1) and invasive carcinoma (n = 36). The DCIS mass was correctly classified by CUSE for > 83 kPa elasticity cut-off value. The size of the DCIS masses was 66 mm with a 175 kPa elasticity value. The 36 invasive cancers had a mean size of 19 mm, with the greatest elasticity values occurring for 11 histological grade III (118.96 ± 10.36 kPa) and 9 lobular cancer (115.7 ± 29.11 kPa) histological types. It should be noted that one patient with an invasive cancer was not given a grade. In all, 32 invasive cancers were correctly classified as positive by CUSE for an elasticity cut-off value of >83 kPa. The four false negatives were attributed to breast masses with small ROI cross-sections less than 0.49 cm 2 (n = 2) and a small ratio of stiffness area to ROI cross-section (n = 2).
In some breast cancers, low shear wave velocity caused by poor-quality shear waves has been reported [42] . Barr and Zheng [43] , using a Siemens S2000 (Siemens Ultrasound, Mountain View, CA, USA), demonstrated that addition of a quality measure (QM) of shear-wave speed estimation can increase shear wave elastography sensitivity for breast cancer. In our study, we used the normalized cross-correlation coefficient as our quality measure. For this study, we did not intend to compare our technique to other available shear wave technologies.
Several aspects of this study will require further investigation. First is the assessment of inter-observer variability, although shear wave elastography techniques have been shown to be highly reproducible [26] . Second is the correction for pre-compression effects on overestimation for the elasticity values of breast masses [44] . Currently, we apply minimal pressure on the ultrasound probe to the skin.
IV. Conclusions
In conclusion, the Young's modulus >83 kPa is an optimal cut-off value for the ROC sensitivity and specificity for our study cohort. This is concordant with previous studies [25] , [37] , [39] . An improvement in the sensitivity and specificity in differentiating benign and malignant breast masses was observed with the additional number of benign cases from our previous study. These results demonstrate that CUSE may be used as a complimentary diagnostic tool to standard breast cancer modalities and could potentially aid in reducing the number of unnecessary biopsies. 
